Developer docs
API playgroundTry for free, no card

Search company profiles

UNI-PHARMA

Full company profile

uuid000eixa

Namestring
UNI-PHARMA
Legal namestring
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
Websiteurl
uni-pharma.gr
Company typeenum
Private
Founded yearint
1963
Descriptiontext

UNI-PHARMA Kleon Tsetis Pharmaceutical Laboratories S.A. is a privately held Greek pharmaceutical manufacturer founded in 1963 by pharmacist Kleonas Tsetis and now led by his daughter Julia Tsetis as President and CEO. The company researches, develops, produces, and markets a broad portfolio of prescription medicines (e.g., T4, Salospir Trebon), OTC products (e.g., Apotel, Trebon Grippe day & night), patented food supplements (Hepatrat, TONOSAN, Lactolevure Cran), medical devices, dermocosmetics, and herbal/natural products via its UniHerbo subsidiary. Manufacturing is anchored in a GMP-certified bioclimatic factory in Kifissia operational since 2015, supported by robotic production systems, a renovated historic facility on the Athens-Lamia National Road, and a new warehouse — collectively representing the largest capital deployment in the Greek pharmaceutical sector over the last decade (€120M+).

The company operates a B2B, sales-led go-to-market, distributing through Greek pharmacy networks via a field force of medical representatives targeting healthcare professionals, while exporting internationally through active participation at Vitafoods Europe, WHX Dubai, Arab-Hellenic Health Conference, and AEEDC Dubai. UNI-PHARMA and its sister company InterMed are official suppliers to the UN, UNICEF, and WHO. Research is conducted in collaboration with Greek academic institutions, including Aristotle University of Thessaloniki and the National and Kapodistrian University of Athens, with 45+ internal research programs since 2018 and 10 co-funded national/international programs under the General Secretariat for Research and Innovation. Revenue mechanics flow through prescription recurring volume for Rx products, one-time unit sales for OTC, supplements, and medical devices, and direct institutional contracts with international organizations — pricing is regulated by national pharmaceutical frameworks and not publicly disclosed.

Short descriptiontext

UNI-PHARMA is a privately held Greek pharmaceutical manufacturer founded in 1963, producing prescription medicines, OTC drugs, patented food supplements, and medical devices under GMP standards for domestic and international B2B customers including the UN, UNICEF, and WHO.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersThessaloníki, Greece
HQ citystring
Thessaloníki
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, prescription medicines, food supplements, GMP-certified production, medical devices
Industry3 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Medicines
TypeOthers
Description

Pharmaceutical products requiring medical prescription including branded medications such as T4, Apotel, Salospir, Trebon, and Trebon Grippe day & night

uni-pharma.gr
2Non-Prescription (OTC) Medicines
TypeOne Time License
Description

Over-the-counter pharmaceutical products available without prescription

uni-pharma.gr
3Food Supplements
TypeOne Time License
Description

Dietary supplements including vitamins, probiotics, joint health products, immune support, and gastrointestinal health products such as Lactolevure Cran, Hepatrat, and TONOSAN

uni-pharma.gr
4Medical Devices
TypeOne Time License
Description

Medical device products for healthcare applications

uni-pharma.gr
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Lactolevure Cran
Description

Cranberry-probiotic-vitamin C dietary supplement product marketed by UNI-PHARMA for UTI prevention in children.

supplysidesj.com
Core offering1 text field

UNI-PHARMA researches, develops, manufactures, and markets a diversified portfolio of pharmaceutical products under high GMP standards. Its offerings span branded prescription medicines (T4, Apotel, Salospir Trebon, Trebon Grippe day & night), over-the-counter medicines, food supplements (Hepatrat, TONOSAN Men's LBD Boost, Lactolevure Cran), medical devices, dermocosmetics, oral-care products, antimosquito/antiviral products, and selected food items, serving healthcare professionals, pharmacies, and institutional customers domestically and internationally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Nearly 70% of children had no UTI infections during follow-up period in clinical study of Lactolevure Cran
Product overview1 text field

UNI-PHARMA is a Greek pharmaceutical company that manufactures and markets a diverse portfolio of pharmaceutical products and dietary supplements. The product portfolio includes prescription and non-prescription medicines (such as T4, Apotel, Salospir Trebon, Trebon Grippe day & night), medical devices, food supplements (including probiotics, vitamins, and supplements for joint/bone health, immune support, and gastrointestinal function), dermocosmetics, oral cavity products, and antimosquito products. The company operates under GMP standards and has invested significantly in research and innovation, developing patented products like Hepatrat and TONOSAN.

Product and service11 records
1Lactolevure Cran
CategoryFood Supplement
Description

Cranberry-probiotic-vitamin C dietary supplement containing 36 mg PACs from cranberry, 6 billion CFUs of Lactobacillus rhamnosus and Bifidobacterium longum, and 250 mg vitamin C; clinically studied for reducing UTIs in pediatric patients.

2T4
CategoryPrescription Medicine
Description

Thyroid medication (levothyroxine) included in UNI-PHARMA's portfolio of pioneering pharmaceutical preparations.

3Apotel
CategoryNon-Prescription Medicine
Description

Over-the-counter analgesic and antipyretic medication available without prescription.

4Salospir Trebon
CategoryNon-Prescription Medicine
Description

Non-prescription medication included in UNI-PHARMA's pharmaceutical product portfolio.

5Trebon Grippe day & night
CategoryNon-Prescription Medicine
Description

Day and night cold/flu medication formulation from UNI-PHARMA's pharmaceutical portfolio.

6Hepatrat
CategoryFood Supplement
Description

Innovative dietary supplement in a bilayer tablet formulation with European Patent (EP4181693B1) for patients with fatty liver disease.

7TONOSAN Men's LBD Boost
CategoryFood Supplement
Description

Patented men's health formulation designed to support men's wellbeing and Libido (LBD) boost.

8Medical Devices
CategoryMedical Device
Description

Medical device products manufactured or distributed by UNI-PHARMA for healthcare applications.

9Skin Cosmetics (Dermocosmetics)
CategoryDermocosmetics
Description

Skincare and cosmetic (dermocosmetic) products manufactured by UNI-PHARMA.

10Oral Cavity Products
CategoryConsumer Health
Description

Oral cavity and dental health products manufactured by UNI-PHARMA.

11Antimosquito & Antiviral Products
CategoryConsumer Health
Description

Antimosquito and antiviral topical and consumer health products.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeOthersAnnounced on2023-11-01
Description

Award recognition: UNI-PHARMA named Growth Winner among 6 top companies from 8,000 assessed for significant development footprint and export orientation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

InterMed is part of the Tsetis Pharmaceutical Group alongside UNI-PHARMA. Both companies are internationally recognized as official suppliers to UN, UNICEF, and WHO. InterMed participated at AEEDC Dubai with scientific presentations on dental implants and both companies participate together at international exhibitions like Vitafoods Europe.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Researchers at Aristotle University conducted a prospective clinical study evaluating UNI-PHARMA's Lactolevure Cran cranberry-probiotic-vitamin C supplement on 39 children with recurrent UTIs, finding nearly 70% had no infections during follow-up.

4Greek Academic and Research Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UNI-PHARMA executes over 45 internal research programs in collaboration with Greek Academic and Research Institutions since 2018. The company also participates as industrial partner in 10 national/international research programs co-funded through the General Secretariat for Research and Innovation.

uni-pharma.gr
5Kleon Tsetis Foundation (AMKE)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The non-profit foundation established by the Tsetis family has funded 30 research programs through scholarships and grants, supports NKUA Cardiology Clinics with academic scholarships, and established scholarships in memory of Garifallia Psarrakou for Pharmacy department research.

uni-pharma.gr
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NKUA is a key academic partner for research collaborations. UNI-PHARMA donated 106 defibrillators to NKUA in memory of Professor Ioanna Andreadou. The Kleon Tsetis Foundation provides scholarships and research support to NKUA's Department of Pharmacy and Cardiology Clinics.

Strategic tierMinorTypeOthers
Description

UNI-PHARMA and InterMed are proud members of UN Global Compact, supporting its 10 principles including climate action, anti-corruption, and sustainable development.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Greek pharmaceutical manufacturer founded in 1965 with prescription, OTC, and consumer health portfolios, and an established export network — the closest comparable mid-sized Greek pharma producer.

TypeDirect peer
Description

Greece's largest domestic pharmaceutical manufacturer producing branded generics and specialty products with strong Greek retail pharmacy penetration and growing exports.

TypeDirect peer
Description

Long-established Greek pharmaceutical manufacturer (founded 1928) with branded prescription medicines, hospital injectables, and consumer health — directly comparable portfolio breadth and Greek-centric distribution model.

TypeDirect peer
Description

Greek contract development and pharmaceutical manufacturer supplying prescription generics and OTC products domestically and abroad; comparable in scale, GMP operations, and route-to-market.

TypeDirect peer
Description

Greek pharmaceutical and personal-care manufacturer with consumer health, OTC, and dermo-cosmetic lines sold through domestic pharmacy distribution — overlapping UNI-PHARMA's food supplement and dermo-cosmetic verticals.

TypeDirect peer
Description

Greek pharmaceutical manufacturer producing generics, OTC, and food supplements with Greek retail-pharmacy focus — directly comparable footprint and category mix.

TypeBroad incumbent
Description

Global pharmaceutical development and contract manufacturing organisation operating at massively larger scale; relevant as a benchmark for UNI-PHARMA's CDMO ambitions and as a competing bidder on European institutional tenders.

TypeBroad incumbent
Description

One of Europe's largest CDMOs with broad manufacturing capabilities for pharma and consumer health; useful overlap for UNI-PHARMA's potential CDMO contract business and international benchmark.

TypeBroad incumbent
Description

Large multinational consumer self-care and OTC pharmaceutical company; competitive overlap with UNI-PHARMA's OTC and supplement portfolio in European and international pharmacy channels.

10Bayer Consumer Health
TypeBroad incumbent
Description

Global OTC and consumer health division of Bayer AG; competes head-to-head with UNI-PHARMA in food supplement and OTC categories across international pharmacy distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UNI-PHARMA

Pharmaceutical Manufacturinguni-pharma.gr

UNI-PHARMA is a privately held Greek pharmaceutical manufacturer founded in 1963, producing prescription medicines, OTC drugs, patented food supplements, and medical devices under GMP standards for domestic and international B2B customers including the UN, UNICEF, and WHO.

What UNI-PHARMA does

UNI-PHARMA Kleon Tsetis Pharmaceutical Laboratories S.A. is a privately held Greek pharmaceutical manufacturer founded in 1963 by pharmacist Kleonas Tsetis and now led by his daughter Julia Tsetis as President and CEO. The company researches, develops, produces, and markets a broad portfolio of prescription medicines (e.g., T4, Salospir Trebon), OTC products (e.g., Apotel, Trebon Grippe day & night), patented food supplements (Hepatrat, TONOSAN, Lactolevure Cran), medical devices, dermocosmetics, and herbal/natural products via its UniHerbo subsidiary. Manufacturing is anchored in a GMP-certified bioclimatic factory in Kifissia operational since 2015, supported by robotic production systems, a renovated historic facility on the Athens-Lamia National Road, and a new warehouse — collectively representing the largest capital deployment in the Greek pharmaceutical sector over the last decade (€120M+).

The company operates a B2B, sales-led go-to-market, distributing through Greek pharmacy networks via a field force of medical representatives targeting healthcare professionals, while exporting internationally through active participation at Vitafoods Europe, WHX Dubai, Arab-Hellenic Health Conference, and AEEDC Dubai. UNI-PHARMA and its sister company InterMed are official suppliers to the UN, UNICEF, and WHO. Research is conducted in collaboration with Greek academic institutions, including Aristotle University of Thessaloniki and the National and Kapodistrian University of Athens, with 45+ internal research programs since 2018 and 10 co-funded national/international programs under the General Secretariat for Research and Innovation. Revenue mechanics flow through prescription recurring volume for Rx products, one-time unit sales for OTC, supplements, and medical devices, and direct institutional contracts with international organizations — pricing is regulated by national pharmaceutical frameworks and not publicly disclosed.

UNI-PHARMA firmographics

Firmographics
Name
UNI-PHARMA
Legal name
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
Website
https://uni-pharma.gr
Company type
Private
Founded year
1963
Operating status
Operating
Headcount range
251–500 employees
Short description
UNI-PHARMA is a privately held Greek pharmaceutical manufacturer founded in 1963, producing prescription medicines, OTC drugs, patented food supplements, and medical devices under GMP standards for domestic and international B2B customers including the UN, UNICEF, and WHO.
Ownership category
akta.pro rank

UNI-PHARMA industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical manufacturing
  • Prescription medicines
  • Food supplements
  • GMP-certified production
  • Medical devices

Where UNI-PHARMA is headquartered

Location

Headquarters

HQ city
Thessaloníki
HQ country
Greece
HQ region
Europe

Offices2 records

Markets served

UNI-PHARMA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Prescription Medicines: Pharmaceutical products requiring medical prescription including branded medications such as T4, Apotel, Salospir, Trebon, and Trebon Grippe day & night
  2. Non-Prescription (OTC) Medicines: Over-the-counter pharmaceutical products available without prescription
  3. Food Supplements: Dietary supplements including vitamins, probiotics, joint health products, immune support, and gastrointestinal health products such as Lactolevure Cran, Hepatrat, and TONOSAN
  4. Medical Devices: Medical device products for healthcare applications

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

UNI-PHARMA product offering

Product offering

Core offering

UNI-PHARMA researches, develops, manufactures, and markets a diversified portfolio of pharmaceutical products under high GMP standards. Its offerings span branded prescription medicines (T4, Apotel, Salospir Trebon, Trebon Grippe day & night), over-the-counter medicines, food supplements (Hepatrat, TONOSAN Men's LBD Boost, Lactolevure Cran), medical devices, dermocosmetics, oral-care products, antimosquito/antiviral products, and selected food items, serving healthcare professionals, pharmacies, and institutional customers domestically and internationally.

Product overview

UNI-PHARMA is a Greek pharmaceutical company that manufactures and markets a diverse portfolio of pharmaceutical products and dietary supplements. The product portfolio includes prescription and non-prescription medicines (such as T4, Apotel, Salospir Trebon, Trebon Grippe day & night), medical devices, food supplements (including probiotics, vitamins, and supplements for joint/bone health, immune support, and gastrointestinal function), dermocosmetics, oral cavity products, and antimosquito products. The company operates under GMP standards and has invested significantly in research and innovation, developing patented products like Hepatrat and TONOSAN.

Differentiator

Problem solved

Functional benefit

Brands

  • Lactolevure Cran: Cranberry-probiotic-vitamin C dietary supplement product marketed by UNI-PHARMA for UTI prevention in children.

Products and services

  • Lactolevure Cran Cranberry-probiotic-vitamin C dietary supplement containing 36 mg PACs from cranberry, 6 billion CFUs of Lactobacillus rhamnosus and Bifidobacterium longum, and 250 mg vitamin C; clinically studied for reducing UTIs in pediatric patients.
  • T4 Thyroid medication (levothyroxine) included in UNI-PHARMA's portfolio of pioneering pharmaceutical preparations.
  • Apotel Over-the-counter analgesic and antipyretic medication available without prescription.
  • Salospir Trebon Non-prescription medication included in UNI-PHARMA's pharmaceutical product portfolio.
  • Trebon Grippe day & night Day and night cold/flu medication formulation from UNI-PHARMA's pharmaceutical portfolio.
  • Hepatrat Innovative dietary supplement in a bilayer tablet formulation with European Patent (EP4181693B1) for patients with fatty liver disease.
  • TONOSAN Men's LBD Boost Patented men's health formulation designed to support men's wellbeing and Libido (LBD) boost.
  • Medical Devices Medical device products manufactured or distributed by UNI-PHARMA for healthcare applications.
  • Skin Cosmetics (Dermocosmetics) Skincare and cosmetic (dermocosmetic) products manufactured by UNI-PHARMA.
  • Oral Cavity Products Oral cavity and dental health products manufactured by UNI-PHARMA.
  • Antimosquito & Antiviral Products Antimosquito and antiviral topical and consumer health products.

Quantifiable outcome

  • Nearly 70% of children had no UTI infections during follow-up period in clinical study of Lactolevure Cran

Companies that use UNI-PHARMA

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

UNI-PHARMA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

UNI-PHARMA partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • Grant Thornton & EurobankminorOthers · 1 November 2023Award recognition: UNI-PHARMA named Growth Winner among 6 top companies from 8,000 assessed for significant development footprint and export orientation.
  • InterMedcoreStrategic or Co-development PartnerInterMed is part of the Tsetis Pharmaceutical Group alongside UNI-PHARMA. Both companies are internationally recognized as official suppliers to UN, UNICEF, and WHO. InterMed participated at AEEDC Dubai with scientific presentations on dental implants and both companies participate together at international exhibitions like Vitafoods Europe.
  • Aristotle University of ThessalonikicoreStrategic or Co-development PartnerResearchers at Aristotle University conducted a prospective clinical study evaluating UNI-PHARMA's Lactolevure Cran cranberry-probiotic-vitamin C supplement on 39 children with recurrent UTIs, finding nearly 70% had no infections during follow-up.
  • Greek Academic and Research InstitutionscoreStrategic or Co-development PartnerUNI-PHARMA executes over 45 internal research programs in collaboration with Greek Academic and Research Institutions since 2018. The company also participates as industrial partner in 10 national/international research programs co-funded through the General Secretariat for Research and Innovation.
  • Kleon Tsetis Foundation (AMKE)coreStrategic or Co-development PartnerThe non-profit foundation established by the Tsetis family has funded 30 research programs through scholarships and grants, supports NKUA Cardiology Clinics with academic scholarships, and established scholarships in memory of Garifallia Psarrakou for Pharmacy department research.
  • National and Kapodistrian University of Athens (NKUA)coreStrategic or Co-development PartnerNKUA is a key academic partner for research collaborations. UNI-PHARMA donated 106 defibrillators to NKUA in memory of Professor Ioanna Andreadou. The Kleon Tsetis Foundation provides scholarships and research support to NKUA's Department of Pharmacy and Cardiology Clinics.
  • UN Global CompactminorOthersUNI-PHARMA and InterMed are proud members of UN Global Compact, supporting its 10 principles including climate action, anti-corruption, and sustainable development.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

UNI-PHARMA competitors and assessment

Company assessment

Direct peers

  • ELPEN Pharmaceutical: Greek pharmaceutical manufacturer founded in 1965 with prescription, OTC, and consumer health portfolios, and an established export network — the closest comparable mid-sized Greek pharma producer.
  • Demo SA: Greece's largest domestic pharmaceutical manufacturer producing branded generics and specialty products with strong Greek retail pharmacy penetration and growing exports.
  • Vianex SA: Long-established Greek pharmaceutical manufacturer (founded 1928) with branded prescription medicines, hospital injectables, and consumer health — directly comparable portfolio breadth and Greek-centric distribution model.
  • Help Pharmaceuticals: Greek contract development and pharmaceutical manufacturer supplying prescription generics and OTC products domestically and abroad; comparable in scale, GMP operations, and route-to-market.
  • Lavipharm: Greek pharmaceutical and personal-care manufacturer with consumer health, OTC, and dermo-cosmetic lines sold through domestic pharmacy distribution — overlapping UNI-PHARMA's food supplement and dermo-cosmetic verticals.
  • Faran SA: Greek pharmaceutical manufacturer producing generics, OTC, and food supplements with Greek retail-pharmacy focus — directly comparable footprint and category mix.

Broad incumbents

  • Catalent: Global pharmaceutical development and contract manufacturing organisation operating at massively larger scale; relevant as a benchmark for UNI-PHARMA's CDMO ambitions and as a competing bidder on European institutional tenders.
  • Aenova Group: One of Europe's largest CDMOs with broad manufacturing capabilities for pharma and consumer health; useful overlap for UNI-PHARMA's potential CDMO contract business and international benchmark.
  • Perrigo Company: Large multinational consumer self-care and OTC pharmaceutical company; competitive overlap with UNI-PHARMA's OTC and supplement portfolio in European and international pharmacy channels.
  • Bayer Consumer Health: Global OTC and consumer health division of Bayer AG; competes head-to-head with UNI-PHARMA in food supplement and OTC categories across international pharmacy distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

UNI-PHARMA social profiles

Digital presence

UNI-PHARMA compliance and trust

Trust signal

Compliance1 record

UNI-PHARMA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UNI-PHARMA leadership team

Management profile

Number of profiles

Profiles2 records

UNI-PHARMA subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

UNI-PHARMA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UNI-PHARMA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UNI-PHARMA

What does UNI-PHARMA do?

UNI-PHARMA researches, develops, manufactures, and markets a diversified portfolio of pharmaceutical products under high GMP standards. Its offerings span branded prescription medicines (T4, Apotel, Salospir Trebon, Trebon Grippe day & night), over-the-counter medicines, food supplements (Hepatrat, TONOSAN Men's LBD Boost, Lactolevure Cran), medical devices, dermocosmetics, oral-care products, antimosquito/antiviral products, and selected food items, serving healthcare professionals, pharmacies, and institutional customers domestically and internationally.

Is UNI-PHARMA a public or private company?

UNI-PHARMA is a private company. It is classified as family owned and is currently operating.

When was UNI-PHARMA founded?

UNI-PHARMA was founded in 1963. It employs 251 to 500 people.

Where is UNI-PHARMA based?

UNI-PHARMA is headquartered in Thessaloníki, Greece, in the Europe region.

How does UNI-PHARMA make money?

Four revenue lines are on record. Prescription Medicines are the primary driver. The others are non-Prescription (OTC) Medicines, food Supplements and medical Devices.

Who are UNI-PHARMA's main competitors?

Direct peers on record are ELPEN Pharmaceutical, Demo SA, Vianex SA, Help Pharmaceuticals, Lavipharm and Faran SA. Broad incumbents are Catalent, Aenova Group, Perrigo Company and Bayer Consumer Health.

Does UNI-PHARMA have an API?

No public API is recorded for UNI-PHARMA.

What industry is UNI-PHARMA in?

UNI-PHARMA's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals